← Browse by Condition
Medical Condition

cd7 positive relapsed refractory t lymphoblastic leukemia lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07188610 Phase 2
Recruiting

PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

Enrollment
100 pts
Location
China
Sponsor
PersonGen BioTherapeutics (Suz...
View Trial →